Synaptica is a biomedical startup founded by Dr. Marijn Martens, developing AI-driven and computational tools that translate ion channel research into clinical applications. Synaptica’s proprietary computational models predict the functional impact of more than 600,000 ion channel variants, supporting clinicians in diagnosing channelopathies. Using ultra-fast machine learning algorithms, we deliver highly accurate in silico predictions to enable precision treatment for channelopathies. Synaptica’s mission is clear: to reshape the future of personalized neurocare by combining cutting-edge technology with neuroscience expertise

Founders:
Marijn Martens (PhD)

Complies with the following Sustainable Development Goals:
SDG 3: Good Health and Well-being

Contact information:

Website: www.synaptica.nl
Mail: marijn.martens@synaptica.nl